MIR2276

Across TCGA pan-cancer cohorts, MIR2276 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR2276’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR2276 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR2276 is over-expressed in tumor, although a few such as LUSC and KIRC show the opposite, repressed pattern.

STAD, LUSC, and KIRC are the cancer types where MIR2276 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR2276 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.393	.001	4	view →
LUSC	Male	All	−0.126	.013	2	view →
KIRC	All	II,III,IV	−0.103	.015	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR2276–STAD

Open the STAD breakdown →